Lithopone B301
...
2025-08-15 18:18
473
Lithopone B301
The FDA is reviewing the safety of titanium dioxide in response to an April petition from EWG and other environmental and public health groups. This is the FDA’s first comprehensive review of titanium dioxide since 1973.
Throughout the fourth quarter of 2021, the European market had consistent optimistic sentiment. Despite the overwhelming inventories at lower levels during the fourth quarter of 2021, the demand prognosis in the domestic market revealed varied opinions. Imports from the Asia Pacific region, on the other hand, remained disruptive due to limited accessibility of vessel freights and a decrease in the PMI index for titanium dioxide in China despite the application of severe environmental protection measures.